Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.

Also called NCT02527811

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
Techpool Bio-Pharma Co., Ltd. (from the registry)
Registry
  • NCT NCT02527811
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02527811. Randomized; single masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2018-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
Condition
Congenital Heart Diseases
Intervention (Drug)
Ulinastatin
Lead sponsor
Techpool Bio-Pharma Co., Ltd. (class: industry)
Collaborator
Shanghai Children's Medical Center (class: other)
Collaborator
Guangzhou Women and Children's Medical Center (class: other)
Collaborator
Guangzhou General Hospital of Guangzhou Military Command (class: other)
Collaborator
Nanjing Children's Hospital (class: other)
Collaborator
Children's Hospital of Fudan University (class: other)

Record details

Record id
cardio:ct-nct02527811
Content hash
119d3e6f132881902ba02783fe69cdfa3999db488b741d37fe0f27d759426451